What if every
emergency department could stop bleeding faster?

What if every cancer center had access to life-sustaining platelet-based products?

What if platelet shortages during natural disasters could be eliminated?

Next generation platelet-based therapeutics

Revolutionizing platelet-based therapies

Cellphire Therapeutics is developing next generation platelet-based therapeutics that are long-term shelf stable and could more rapidly treat bleeding.

Until now, donated platelets had a shelf life of 5 to 7 days. But our patented technology allows us to freeze-dry platelets—stabilizing them—so they can last for years. Our investigational product, Thrombosomes®, once approved, could be given to anyone, anywhere, any time.

About our science

Join Our Team

Discover yourself at Cellphire

We are looking for talented, innovative people to join us as we work to make a difference in the lives of patients. Learn more about the work we do, our team, and the benefits we have to offer.

Clinical Trials and Research

Upcoming Clinical Trials

Cellphire is actively recruiting study sites for two Phase 2 clinical trials.

Research & Development

We are continually exploring new applications for platelet-based therapies.

Want to hear more about our trials and research?

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.